Encephalitis is a severe inflammatory disorder of the brain with many possible causes and a
complex differential diagnosis. Advances in autoimmune encephalitis research in the past …

Autoimmune encephalitis defines brain inflammation caused by a misdirected immune
response against self-antigens expressed in the central nervous system. It comprises a …

Objective The contemporary diagnosis of paraneoplastic neurologic syndromes (PNSs)
requires an increasing understanding of their clinical, immunologic, and oncologic …

Investigations in the last 10 years have revealed a new category of neurological diseases
mediated by antibodies against cell surface and synaptic proteins. There are currently 16 …

Faciobrachial dystonic seizures and limbic encephalitis closely associate with antibodies to
leucine-rich glioma-inactivated 1 (LGI1). Here, we describe 103 consecutive patients with …

Objective: To report a large cohort of patients with antibodies against contactin-associated
protein-like 2 (Caspr2) and provide the clinical spectrum of this disorder. Methods: Serum …

Background and Objectives To determine the real-world use of rituximab in autoimmune
encephalitis (AE) and to correlate rituximab treatment with the long-term outcome. Methods …

Objective: We investigated a series of patients with LGI1 antibody (Ab)–related cognitive
deterioration to determine the clinical presentation, long-term outcome, and LGI1 Ab …

Over the past 10 years, the continual discovery of novel forms of encephalitis associated
with antibodies to cell‐surface or synaptic proteins has changed the paradigms for …

The rapid expansion in the number of encephalitis disorders associated with autoantibodies
against neuronal proteins has led to an incremental increase in use of the term “autoimmune …